Participants 352 405 3
patients with heparin-induced thrombocytopenia (HIT).
Participants 598 631 3
patients undergoing elective PCI.
Participants 655 912 7
140 patients randomized to three argatroban dose groups (ARG250, ARG300, and ARG350 with 250, 300, or 350 μg/kg bolus, followed by 15, 20, or 25 μg/kg/min infusion) and one unfractionated heparin (UFH) group (70-100 IU/kg bolus), 138 patients were analyze
